Adenylate cyclase deˆcient (cya) mutants of E. coli K-12 were found to be resistant to fosmidomycin, a speciˆc inhibitor of the non-mevalonate pathway, just like to fosfomycin. E. coli glpT mutants were resistant to fosfomycin and also to fosmidomycin. This fact shows that fosmidomycin was transported inside via the glycerol-3-phosphate transporter, GlpT. DNA microarray analysis showed that the transcription of glpT and other genes concerning glycerol utilization were highly dependent on the presence of cAMP.
Fosmidomycin (FR-31564) is an antibiotic that has a C-P bond and is eŠective on various Gram-positive and Gram-negative bacteria (Fig. 1) .
1) The target of it, however, had long been unknown. Recently Seto and his group found that 1-deoxy-D-xylulose 5-phosphate (DXP) reductoisomerase in the nonmevalonate pathway is the target of fosmidomycin.
2)
The antibiotic is thought to inhibit the enzyme as a structural analogue. The non-mevalonate pathway wasˆrstly found by Rohmer et al. in Zymomonas mobilis. 3, 4) Now it is known that non-mevalonate pathway is widely distributed in bacteria including Escherichia coli, Salmonella typhimurium, Bacillus subtilis, and Clostridium acetobutyricum as an alternative to the mevalonate pathway. Theˆrst enzyme in the pathway is DXP synthetase, which catalyzes the formation of DXP from pyruvate and D-glyceraldehyde-3-phosphate.
5) The second enzyme, DXP reductoisomerase, catalyzes NADPH-dependent reaction from DXP to 2-C-methyl-D-erythritol 4-phosphate, a preceding metabolite to isopentenyl diphosphate. 6, 7) Fosfomycin (phosphonomycin) is another wellknown antibiotic which has a C-P bond (Fig. 1) . 8, 9) Its target is known as the enzyme forming UDP-Nacetylmuramic acid from UDP-N-acetyl glucosamine and phosphoenolpyruvic acid. 10) Thus fosfomycin is an antibiotic that inhibits bacterial peptidoglycan synthesis. It has been known that cya or crp mutants of Salmonella typhimurium are resistant to fosfomycin. 11) cya and crp genes encode adenylate cyclase and cAMP receptor protein, respectively. Fosfomycin resistance in the bacterium is, therefore, dependent on the lack of cAMP-function.
From the structural similarity of fosmidomycin to fosfomycin in relation to the C-P bond region, we examined fosmidomycin resistance in cya mutants of E. coli. E. coli K-12 derivative HT28 strain (Dcya::Km) and its parent W3110 (F -, thy, l) were kindly provided by H. Aiba. 12) Another E. coli K-12-derived cya mutant, CA8306 (Dcya, relA) and its parents CA8000 (HfrH, relA, thi, l) were kindly provided some years ago by J. Beckwith. 13, 14) The minimum inhibitory concentration (MIC) was measured by an agar plate-paper disc method using paper discs (8 mm in diameter, Advantec, Tokyo, Japan) and nutrient agar plates. Nutrient agar was the product of Eiken Chemical Co. (Tokyo, Japan). Fosfomycin and cAMP were purchased from Wako Pure Chemical Co. (Osaka, Japan). Fosmidomycin was supplied from Fujisawa Pharmaceutical Industry (Osaka, Japan). As shown in Table I both Dcya All log 10 intensity ratios of the gene of E. coli W3110 W HT28 are represented in the scatter plot, with each circle indicating the log 10 expression ratio of an individual gene. Genes more highly expressed in W3110 (CA8000) are shown above the centerline, while those below the centerline are more highly expressed in HT28 (CA8306). Lines indicate the standard of the signiˆcant expression (2.0 times). Gene numbers in (A) and (B) are diŠerent.
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Fosmidomycin Resistance in E. coli mutants, HT28 and CA8306 were resistant to fosmidomycin as well as to fosfomycin but sensitive if they were cultivated in the presence of 1 mM cAMP. It is known that fosfomycin is transported into E. coli cells via the glycerol-3-phosphate transporter (GlpT) and in part via the hexose phosphate transporter. 10, 15) The expression of glpT is known to be dependent on the presence of cAMP.
11) From the study on cross-resistance to fosfomycin and fosmidomycin, both antibiotics were suggested to be transported inside via GlpT in Pseudomonas aeruginosa. 16) We tested fosmidomycin resistance in two mutants of E. coli K-12 derived glpT mutans, ME7760 and ME8261. The mutants were obtained from the National Institute of Genetics (Mishima, Japan). Both glpT mutants were resistant to fosmidomycin and fosfomycin (Table 1 ). This fact shows that fosmidomycin was transported inside via the glycerol-3-phosphate transporter, GlpT.
We examined the cAMP-dependence of glpT gene expression by using an E. coli K-12 DNA micro-array (Takara Bio Inc., Otsu, Japan). E. coli strains to be tested were grown aerobically to the mid-exponential phase in L-tubes containing 10 ml of LB broth. Total RNA of E. coli cells (ca. 5×10 8 ) was prepared using a Rneasy Mini Kit (Qiagen K. K., Tokyo, Japan) according to its protocol with RNAprotect Bacteria Reagent (Qiagen K. K.) as a stabilizer of RNA. The RNA was routinely puriˆed. The puriˆed RNA samples should be above 1.85 in A260 W A280. The reverse transcriptase reaction was done with a RNA Fluorescence Labeling Core Kit (M-MLV Version) (Takara Bio Inc.) with the mixed primer and FluoroLink Cy3-and Cy5-dUTP, according to the protocol of the manufacturer. Fluorescence-labeled cDNAs were puriˆed, precipitated with ethanol, and dissolved in a hybridization buŠer (6×SSC, 0.2z sodium dodecyl sulfate, 5×Denhardt's solution, and 0.1 mg W ml denatured salmon sperm DNA). The hybridization was done with an IntelliGene DNA Chip (Takara Bio Inc.) and Spaced Cover Glass (Takara Bio Inc.) according to the protocol at 659 C for 16 hours. The micro-array was routinely rinsed. The scanning of the DNA micro-arrays was done at DNA Chip Research (Yokohama, Japan) with CRBIOIIe (Hitachi Software Engineering Co., Ltd., Yokohama Japan). DNA-microarray experiments were done twice, and the results were reproducible.
As shown in Fig. 2 , glpT and other glycerol metabolism-related genes, glpQ, glpA, glpB, and glpC had a high gene expression ratio in both parent W Dcya mutant sets. The glpABC operon, at 50.7 min in the E. coli K-12 genetic map, encodes the three subunits of glycerol-3-phosphate dehydrogenase (EC 1.1.99.5) and its transcription direction is clockwise to the map.
17) The glpTQ operon, at 50.6 min in the genetic map, encodes glycerol-3-phosphate permease and glycerol-3-phosphate diesterase, respectively. The transcription direction is opposite to that of the glpABC operon. 17) Both operons have cAMP receptor protein (CRP)-binding boxes in their 5?-control regions. 18, 19) These situations well explain the coordinated high expression of the genes in each operon. Both operons are under the control of GlpR, the repressor for the glp regulon. To our surprise, the glpTQ operon and glpABC operon were within the highest 100 group among ca. 4500 genes in geneexpression ratio between the wild strain (parent) and Dcya mutant in the DNA mirco-array assay (Fig. 2) .
The high gene expression ratio, in the top 100 class, of PTS sugar enzyme II genes was also remarkable. Their gene names are cited in the lower region of either Fig. 2A or Fig. 2B . manX, manZ, and nagE encode Enzyme II A (Man), Enzyme II B (Man) and Enzyme II (GlcNAc), respectively. And ptkB, ptkC, and ptsG encode Enzyme II (galactitol), Enzyme II C (galactitol), and Enzyme II (Glc), respectively. The high gene expression ratio of these genes makes a sharp contrast to the low response ratio of the ptsHIcrr operon, which has a CRP binding site in the 5?-control region. ptsH and ptsI genes, shown in the parenthesis in the lower region of either Fig. 2A or Fig. 2B , encode HPr and Enzyme I, respectively. HPr and Enzyme I are the common components for various sugar-speciˆc Enzyme IIs in the phosphotransferase system. To our best knowledge this is an early attempt on the DNA micro-array analysis concerning the eŠects of cAMP on an E. coli gene expression proˆle.
In conclusion E. coli K-12 Dcya mutants were resistant to fosmidomycin. The antibiotic was shown to be transported inside via the glycerol-3-phosphate transporter, GlpT. The expression of glpT and other genes concerning glycerol utilization was highly dependent on the presence of cAMP.
